Walmart pushed pharmacy discounts up to 85% through Walmart+ RX, bypassing insurance

The world's largest retailer, with a significant physical pharmacy footprint ranked fifth in US pharmacy revenue.

Walmart already ran a large in-store pharmacy business. In June 2021, one day after rival Amazon's latest drug-pricing push, it announced new discounts of up to 85% on prescriptions bought through its Walmart+ RX service.

Customers apply for a savings card that looks like a prescription drug card, usable only at Walmart stores or its website. Walmart works with a pharmacy benefit manager and appears to pass a significant portion of typical rebates to cash customers, letting them sidestep insurance — though not the PBM middleman.

Walmart attacks with its strongest existing asset — physical pharmacies at grocery frequency — while Amazon tries to overcome its mail-pharmacy disadvantage.

The savings card turns the PBM rebate system, normally opaque, into a visible consumer discount, targeting the cash-paying uninsured the system prices highest.

Membership exclusivity (usable only at Walmart) ties drug savings to the broader Walmart+ loyalty play against Amazon Prime.

In markets ruled by secret middlemen rebates, the disruptor's lever is transparent cash pricing to the uninsured — membership programs become the vehicle that makes discount economics work.

The material records the June 2021 announcements and market reaction, noting neither company had yet dented the dominance of CVS and Walgreens; Walmart's discount expansion was live as of the report.